is your point-of-care hospital glucose system meeting the...

4
Is your Point-of-Care hospital glucose system meeting the needs of your critical patients?

Upload: others

Post on 25-Mar-2020

2 views

Category:

Documents


0 download

TRANSCRIPT

Is your Point-of-Care hospital glucose system meeting the needs of your critical patients?

The HemoCue® Glucose 201 DM System

Accurate and Precise Results for Maintaining Glycemic Control

Accurate and reliable glucose readings are important in optimizing diabetes care and ensuring patient safety. Lab-quality results are essential for testing critically ill patients and maintaining glycemic control of diabetic and nondiabetic patients in the hospital environment. The practice of using strip glucose systems for glycemic control in the hospital environment is concerning and problematic.1,2

In multiple studies, the HemoCue® Glucose 201 system has been shown to provide highly accurate and reliable results.

Lab-quality Results Anytime, Anywhere

Total assurance—it comes standard with the HemoCue® Glucose 201 DM Analyzer. Unlike with some strip meters, there are fewer concerns with false “safe target zone” impressions or interference from extremes of hematocrit, p02, bilirubin, or endogenous substances. And with near-patient testing, you have less worry about errors due to glycolysis during sample transportation and preparation.

You can trust the lab-quality results you get from your HemoCue® glucose system when diagnosing and monitoring diabetes as well as when monitoring blood glucose levels in neonates and other critical patients.

HemoCue® glucose analyzers—when accuracy is critical.

When accuracy at the Point-of-Care is critical, why settle for anything less than lab-quality results? As a critical care professional, you should not have to. The HemoCue® Glucose 201 DM Analyzer is among the leading systems for precision and accuracy. Not only does it provide glucose values that can be trusted, but it does so quickly, easily, and efficiently.

Lab-quality Results at the Point-of-Care

Load Device

Take Sample

Read Result

Accurate Products

We strive to make intricate technology simple to use, without compromising accuracy. HemoCue’s advanced glucose technology is based on a glucose dehydrogenase enzymatic reaction. We just simplify, downsize, and speed up the process—giving you results in only minutes with absolute lab accuracy so you can have the confidence to provide the right care faster.

Knowledge

A vital part of ensuring accurate results is giving healthcare professionals easy access to training and education. That’s why we’ve poured our 30 years of experience and knowledge into our HemoCue Learning Center so you can have quick access to essential training and current best practices.

Service

We’ve built a stable infrastructure to ensure that you have what you need when you need it. From our worldwide supply network to local representatives, along with our unmatched HemoCue Solution Center, we provide support and delivery assurance.

More than an excellent product, HemoCue offers personalized education and training and an unmatched service and support infrastructure to meet your needs and those of your patients.

Take Advantage of Complete Solutions and Support

Point-of-Care testing results with central lab accuracy

Data management and data transfer capabilities for optimal record management,

regulatory compliance, and administration

QC management and lockout features that discourage bypassing established

procedures and reduce the risk of reporting incorrect results

Connectivity to a central data management server or clinical information systems

for the secure and accurate transfer of patient test results

The accuracy provided by a clinical lab should never be sacrificed for the convenience of Point-of-Care testing. The HemoCue® Glucose 201 DM Analyzer is engineered to provide results with the same accuracy and precision you expect from a central lab.

Three Easy Steps

REFERENCES:

1 Bill Malone, “Higher Standards on the Way for Glucose Meters?” Clinical Laboratory News, September 2009, Vol 35, No. 9.

2 Margaret Hamburg, M.D., FDA response letter and memorandum to AACE dated June 24, 2009, “The FDA’s Center for Devices and Radiological Health’s Response.”

HemoCue America | California, USAPhone 800.881.1611 | Fax 800.333.7043 | [email protected] | hemocue.com

HemoCue has been a leader in Point-of-Care medical diagnostics for over 30 years. We specialize in giving healthcare providers lab-quality accuracy with results comparable to that of a clinical lab.

©2013 HemoCue America. All rights reserved. LIT 2024 Rev 131008

Respected for Accuracy.Trusted for Diagnosis.

Hemoglobin | Glucose | Urine Albumin | WBC